Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0.524. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: HHSN272201800008C
National Institutes of Health
Grant: P30 AI027757-31
National Institutes of Health
Grant: P51 OD010425
National Institutes of Health
Grant: P01 AI094417
National Institutes of Health
Grant: U19 AI128741
National Institutes of Health
Grant: UM1 AI124377
National Institutes of Health
Grant: R37 AI054292
National Institutes of Health
Grant: P51 OD011092
National Institutes of Health
Grant: HHSN261200800001E
CCR NIH HHS
Grant: HHSN261200800001C
NIAID NIH HHS
Grant: HHSN272201800008I
NIAID NIH HHS
Grant: P30 AI027757
FWCI
3.14
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals